AnaptysBio to Present at J.P. Morgan Annual Healthcare Conference

by NASDAQ Market News January 8, 2020

NASDAQ Market News
Click here to email author

Nabriva Therapeutics Receives FDA Acknowledgement of New Drug Application Resubmission for Intravenous CONTEPO™ (fosfomycin) for Injection

AB Science announces that FDA green-lights U.S. patient enrollment in masitinib Phase 3 study following IND clearance in metastatic castrate-resistant prostate cancer eligible to chemotherapy

Ads